Madrigal Pharmaceuticals, Inc. MDGL Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s accrued manufacturing costs?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported accrued manufacturing costs of $34.33M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s accrued manufacturing costs changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s accrued manufacturing costs increased by 87.9% year-over-year, from $18.27M to $34.33M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s accrued manufacturing costs?
- Over 2 years (2023 to 2025), Madrigal Pharmaceuticals, Inc.'s accrued manufacturing costs has grown at a 101.6% compound annual growth rate (CAGR), from $17.03M to $69.21M.